Non Therapeutic Antibiotics for Food Animals

Non Therapeutic Antibiotics for Food Animals Market Outlook

The global non-therapeutic antibiotics for food animals market is projected to reach approximately USD 4.5 billion by 2035, growing at a compound annual growth rate (CAGR) of about 5.8% from 2025 to 2035. This growth is largely driven by the increasing demand for antibiotic growth promoters in animal husbandry to enhance feed efficiency and overall livestock productivity. Furthermore, the rising awareness among farmers regarding the health benefits of using non-therapeutic antibiotics for food animals is also contributing to market expansion. Additionally, changes in regulatory policies aimed at ensuring food safety and animal welfare are encouraging the adoption of these antibiotics in various geographical regions. The surge in meat consumption, alongside the growing aquaculture industry, further emphasizes the importance of non-therapeutic antibiotics in improving growth rates and disease resistance among food animals.

Growth Factor of the Market

The growth of the non-therapeutic antibiotics for food animals market can be attributed to several key factors, including the increasing adoption of intensive farming practices that maximize production efficiency. As livestock and poultry production scales up, the need for effective feed additives, including non-therapeutic antibiotics, becomes paramount to ensure optimal growth rates and maintain herd health. Additionally, advancements in veterinary medicine and a rising focus on biosecurity measures in farms are further bolstering market demand. Another contributing factor is the growing consumer preference for lean meat and high-quality animal products, which encourages producers to incorporate non-therapeutic antibiotics in their feeding regimes. Moreover, ongoing research into the benefits of these additives in improving feed conversion ratios and enhancing overall animal health supports the market's growth trajectory.

Key Highlights of the Market

• The market is poised to grow at a CAGR of 5.8% from 2025 to 2035.
• Increased demand for non-therapeutic antibiotics in aquaculture is a key driver of growth.
• Regulatory frameworks are evolving to ensure the safe use of antibiotics in food animals.
• Technological advancements in animal nutrition are paving the way for innovative antibiotic formulations.
• Consumer awareness regarding food safety and quality is influencing market dynamics.

By Product Type

Tetracyclines:

Tetracyclines are among the most commonly used non-therapeutic antibiotics in food animals, primarily due to their broad-spectrum efficacy against a wide range of bacteria. These antibiotics are frequently utilized in livestock to enhance growth rates and feed conversion efficiency. The ability of tetracyclines to be administered through feed or water makes them a favorable choice for farmers, facilitating ease of use in large-scale operations. Moreover, the rising incidence of bacterial infections in livestock reinforces the demand for tetracyclines, as they effectively mitigate disease outbreaks. However, concerns over antibiotic resistance and potential regulatory pressures may impact the long-term viability of tetracyclines in animal feeding practices.

Penicillins:

Penicillins, known for their effectiveness in treating a variety of bacterial infections, are also employed in non-therapeutic applications within the food animal sector. These antibiotics help improve overall animal health and welfare by preventing disease and promoting faster weight gain. The increasing focus on sustainable farming practices has led to a growing interest in alternative antibiotics like penicillins, especially due to their relatively lower risk of developing resistance compared to other antibiotic classes. As the global demand for high-quality animal products rises, the use of penicillins as growth promoters will likely remain significant in the market.

Sulfonamides:

Sulfonamides, another class of non-therapeutic antibiotics, are utilized to promote growth and prevent disease in food animals. Their effectiveness against specific bacterial infections has made them a preferred choice among veterinarians and farmers alike. With the increasing awareness of animal welfare and food safety, sulfonamides serve an essential role in enhancing the health and productivity of livestock. Furthermore, the growing trend towards antibiotic-free meat production is pushing manufacturers to explore the development of alternative sulfonamide formulations that meet consumer demands while ensuring animal health.

Macrolides:

Macrolides are typically used in veterinary medicine for their antibacterial properties and are also gaining traction in the non-therapeutic segment. Their unique mechanism of action allows for targeted treatment of gram-positive bacterial infections, making them beneficial for food animals. As producers continue to seek ways to enhance growth rates while minimizing antibiotic resistance, macrolides provide an appealing option. Moreover, the potential for macrolides to be used in conjunction with other growth-promoting agents could further drive their adoption in the food animal industry.

Aminoglycosides:

Aminoglycosides are primarily recognized for their effectiveness against a range of gram-negative bacteria, making them valuable in controlling infections in food animals. Their application as non-therapeutic antibiotics has been instrumental in improving growth performance and feed efficiency among livestock. However, the potential side effects on animal health and concerns about residue in meat products are prompting a careful examination of their use. Regulatory bodies are increasingly scrutinizing the application of aminoglycosides, which may shape their future presence in the food animals market.

By Application

Livestock:

The livestock sector remains a dominant application area for non-therapeutic antibiotics, as these additives play a crucial role in enhancing growth rates and feed efficiency. Farmers of cattle, pigs, and sheep frequently utilize non-therapeutic antibiotics to promote optimal health and weight gain among their animals. The increasing global demand for meat products drives the need for effective strategies to ensure livestock productivity. Furthermore, the pressure to maintain biosecurity on farms has elevated the significance of using non-therapeutic antibiotics as a preventive measure against disease outbreaks, making their application in livestock farming indispensable.

Poultry:

Poultry farming is another critical application for non-therapeutic antibiotics, with these products being employed to improve growth rates and enhance feed conversion efficiency among chickens and turkeys. With the rapid expansion of the poultry sector, driven by consumer preferences for chicken and egg products, the demand for non-therapeutic antibiotics is expected to remain strong. As producers seek ways to enhance their production systems, the use of non-therapeutic antibiotics in poultry remains a vital strategy to combat diseases and optimize growth performance. Regulatory changes and consumer concerns regarding antibiotic use may influence poultry producers' approaches, driving the demand for alternatives in the coming years.

Aquaculture:

Aquaculture is an emerging segment for non-therapeutic antibiotics, and its growth is significantly impacting the overall market. As fish farming becomes increasingly popular to meet global seafood demand, the need for effective health management strategies, including the use of non-therapeutic antibiotics, is paramount. These antibiotics aid in preventing diseases among farmed fish and improving their growth rates. The rising interest in aquaculture as a sustainable food source is likely to bolster demand for non-therapeutic antibiotics in the sector, while ongoing research into antibiotic alternatives may further shape the landscape of aquaculture health management in the future.

By Distribution Channel

Veterinary Clinics:

Veterinary clinics play a crucial role in the distribution of non-therapeutic antibiotics, serving as a primary point of access for farmers seeking veterinary support and pharmaceutical products. These clinics provide professional guidance on the appropriate use of antibiotics and contribute to the overall health management of livestock. The relationship between veterinarians and farmers ensures that the antibiotics are used judiciously and effectively, which is essential for maintaining animal welfare and minimizing resistance development. The growing reliance on veterinary clinics for both consultation and product procurement is likely to drive the distribution channel's continued significance in the market.

Feed Mills:

Feed mills are pivotal in the distribution of non-therapeutic antibiotics, as they directly incorporate these additives into animal feed formulations. The integration of non-therapeutic antibiotics into feed allows for more efficient administration to livestock and poultry, facilitating improved health outcomes and growth performance. As the demand for customized feed formulations increases, feed mills are continuously innovating to meet the specific nutritional and health needs of animals. The collaboration between feed manufacturers and antibiotic suppliers is essential to ensure the quality and efficacy of the products utilized within the industry.

Online Retailers:

Online retailers have emerged as a growing distribution channel for non-therapeutic antibiotics, providing farmers with convenient access to veterinary products. The proliferation of e-commerce has allowed for greater visibility and availability of antibiotic products, enabling farmers to make informed purchasing decisions. The ease of online ordering and delivery supports the timely procurement of antibiotics, which is crucial for maintaining animal health on farms. As digital platforms continue to evolve, the reliance on online retailers for antibiotic distribution is expected to grow, particularly among small-scale producers seeking cost-effective solutions.

Farm Supply Stores:

Farm supply stores remain a traditional yet significant distribution channel for non-therapeutic antibiotics, providing essential products to local farmers and livestock producers. These stores offer a range of veterinary supplies, including antibiotics, that can be readily accessed by farmers in rural areas. The personal relationships between store staff and farmers help facilitate the appropriate use of antibiotics and ensure that farmers receive guidance on best practices. As the need for sustainable farming solutions increases, farm supply stores will continue to play an important role in providing access to non-therapeutic antibiotics while promoting responsible use among their customers.

Others:

Other distribution channels, including direct sales from manufacturers and veterinary pharmaceutical companies, contribute to the availability of non-therapeutic antibiotics in the market. These channels often target larger agricultural operations that require bulk purchases and specialized antibiotic formulations. The direct collaboration between manufacturers and producers enables tailored solutions that meet specific production needs, enhancing the overall effectiveness of antibiotic use in food animals. As the landscape of antibiotic distribution continues to evolve, the emergence of other innovative channels may further redefine how non-therapeutic antibiotics reach the end-users, catering to the diverse needs of the food animal sector.

By Ingredient Type

Chlortetracycline:

Chlortetracycline is widely used as a non-therapeutic antibiotic for food animals, known for its effectiveness against various bacterial infections. Its primary application is in promoting growth and improving feed efficiency in livestock. The ability of chlortetracycline to be administered through water or feed allows for flexible usage in large-scale farming operations. Furthermore, its cost-effectiveness compared to other antibiotics adds to its popularity among producers. However, concerns about antibiotic resistance are leading to increased scrutiny of its use in animal husbandry, prompting manufacturers to explore alternative formulations.

Oxytetracycline:

Oxytetracycline is another key ingredient used in non-therapeutic applications, valued for its broad-spectrum antibacterial properties. This antibiotic is commonly administered to livestock to prevent and control bacterial infections while enhancing growth performance. Its versatility and successful track record in veterinary medicine have solidified its position in the market. However, as regulatory bodies tighten guidelines surrounding antibiotic use, the future of oxytetracycline in non-therapeutic applications will depend on responsible management strategies and the development of effective alternatives.

Sulfamethazine:

Sulfamethazine is increasingly recognized for its role as a non-therapeutic antibiotic in food animals, primarily for its efficacy in promoting weight gain and improving feed efficiency. This ingredient is especially popular in the poultry industry, where it supports the overall health of birds. Its cost-effectiveness further enhances its appeal among producers seeking to improve profitability. Despite its benefits, the growing concern around antibiotic resistance has led to calls for cautious usage and ongoing research into non-antibiotic alternatives that could support animal health without contributing to resistance.

Tylosin:

Tylosin is a macrolide antibiotic frequently used as a non-therapeutic additive in food animal production, particularly in swine and poultry. Known for its effectiveness in promoting growth rates and improving feed conversion ratios, tylosin is valued for its ability to enhance overall production efficiency. Producers appreciate its unique properties that help prevent certain gastrointestinal diseases, contributing to healthier livestock. However, the potential implications of tylosin use on antibiotic resistance are driving research into alternative growth promotion strategies that can maintain productivity without compromising safety.

Neomycin:

Neomycin is an aminoglycoside antibiotic that serves as a crucial ingredient in the non-therapeutic antibiotic segment. Its effectiveness against gram-negative bacteria makes it a valuable tool in treating and preventing infections in food animals. Neomycin is typically used in combination with other antibiotics to enhance their efficacy. While it plays a significant role in health management strategies, its potential for adverse effects and concerns regarding residue in meat products are prompting careful consideration by producers and regulatory authorities alike. Ongoing monitoring and research will be essential to balance the benefits of neomycin with the risks associated with its use.

By Region

The non-therapeutic antibiotics for food animals market is experiencing significant growth across various regions, with North America being one of the largest markets. In North America, the market is fueled by the high demand for meat products and the growing awareness of animal health. As farmers increasingly adopt intensive farming practices, the utilization of non-therapeutic antibiotics is expected to remain robust, leading to a projected market size of approximately USD 1.5 billion by 2035. Additionally, the implementation of stringent regulations regarding antibiotic use is likely to shape the dynamics of the market, directing attention towards more sustainable practices in livestock production.

Europe is another important region for the non-therapeutic antibiotics market, driven by the increasing focus on animal welfare and food safety. The European market is expected to reach around USD 1.2 billion by 2035, growing at a CAGR of 4.5% during the forecast period. Regulatory initiatives, such as the ban on the use of antibiotics for growth promotion in several European countries, have led producers to seek alternatives to maintain productivity. Despite these challenges, the market is witnessing a shift towards more responsible antibiotic use, encouraging innovation in the development of non-antibiotic growth promoters that can support animal health in compliance with regulatory standards.

Opportunities

The non-therapeutic antibiotics for food animals market presents a plethora of opportunities for growth, particularly as the global demand for protein-rich food sources continues to rise. With a burgeoning population and changing dietary preferences, there is an increasing need for efficient animal production systems. This scenario creates opportunities for manufacturers to innovate and develop novel antibiotic formulations that can enhance growth rates and improve feed conversion efficiency without contributing to antibiotic resistance. Furthermore, the emphasis on sustainable farming practices is pushing the industry towards exploring alternatives, including probiotics and other feed additives that can support animal health while minimizing the reliance on traditional antibiotics. The evolution of regulatory frameworks that promote responsible antibiotic use can also open avenues for companies to showcase their commitment to food safety and animal welfare, potentially enhancing their market competitiveness.

Additionally, the expansion of the aquaculture sector presents a significant opportunity for non-therapeutic antibiotics, as fish farming becomes a vital source of protein for consumers. The growing awareness of the health benefits associated with seafood consumption is driving aquaculture production, creating a demand for effective health management strategies. Companies that can successfully integrate non-therapeutic antibiotics into aquaculture practices while addressing concerns related to antibiotic resistance are likely to capture a significant share of this emerging market. With ongoing research and development initiatives aimed at creating targeted antibiotic products tailored to specific animal needs, the landscape of the non-therapeutic antibiotics market is poised for transformation, enabling stakeholders to explore new business avenues that align with evolving consumer expectations and regulatory standards.

Threats

The non-therapeutic antibiotics for food animals market faces several threats that could hinder growth and demand. One of the most pressing issues is the growing concern regarding antibiotic resistance, which poses a significant challenge for public health and animal husbandry alike. As bacteria develop resistance to commonly used antibiotics, the efficacy of these products diminishes, leading to increased health risks for both animals and humans. Regulatory agencies worldwide are increasingly scrutinizing antibiotic use in livestock, leading to stricter guidelines and potential bans on specific classes of antibiotics. These developments may compel producers to reassess their use of non-therapeutic antibiotics, creating uncertainty in the market.

Moreover, consumer preferences are shifting towards antibiotic-free meat products, further complicating the landscape for non-therapeutic antibiotics in food animals. This trend is driven by heightened consumer awareness regarding food safety, animal welfare, and the potential health implications of antibiotic residues in meat. As a result, producers may face pressure to seek alternatives to non-therapeutic antibiotics, leading to decreased market demand. Companies that fail to adapt to these evolving consumer expectations risk losing market share, emphasizing the need for innovation and agility within the industry to remain viable in an increasingly competitive environment.

Competitor Outlook

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim
• Elanco Animal Health
• Ceva Santé Animale
• Phibro Animal Health Corporation
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• Virbac
• PetIQ, Inc.
• Heska Corporation
• Norbrook Laboratories Ltd.
• Tyson Foods, Inc.
• Alltech
• Land O'Lakes, Inc.

The competitive landscape of the non-therapeutic antibiotics for food animals market is characterized by a mix of established pharmaceutical companies and emerging players seeking to capitalize on growth opportunities. Major companies, such as Zoetis and Merck Animal Health, dominate the market by offering a comprehensive portfolio of antibiotics and innovative veterinary solutions tailored to the needs of livestock producers. These key players invest significantly in research and development to create new formulations that address the growing concerns surrounding antibiotic resistance while promoting animal health and productivity. Their strong distribution networks and established relationships with veterinarians and farmers further solidify their position in the market.

In addition to the major players, several smaller companies are actively entering the market, focusing on niche segments and the development of alternative antibiotic products. For instance, companies like Alltech and Phibro Animal Health Corporation are exploring innovative solutions such as probiotics and natural growth promoters that can serve as substitutes for traditional non-therapeutic antibiotics. These emerging players are leveraging advancements in technology and consumer trends to carve out a competitive edge within the industry. As the market evolves, collaboration and partnerships between established companies and startups may lead to the development of novel strategies that address the challenges of antibiotic resistance while meeting the growing demand for sustainable agricultural practices.

As the non-therapeutic antibiotics market continues to adapt to changing regulatory landscapes and consumer preferences, key players remain committed to maintaining their leadership positions through strategic initiatives. For example, Boehringer Ingelheim has focused on sustainability by investing in research aimed at reducing antibiotic use in livestock while promoting alternative solutions. Similarly, Elanco Animal Health has expanded its portfolio to include products that emphasize animal welfare and health, aligning their offerings with consumer expectations. The ongoing trend towards responsible antibiotic use underscores the importance of innovation and adaptability within the competitive landscape, as companies strive to navigate the complexities of the non-therapeutic antibiotics market while ensuring the health and well-being of food animals.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Virbac
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Zoetis
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Alltech
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 PetIQ, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Vetoquinol S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Heska Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Tyson Foods, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Land O'Lakes, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Merck Animal Health
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Boehringer Ingelheim
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Elanco Animal Health
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Ceva Santé Animale
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Dechra Pharmaceuticals PLC
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Norbrook Laboratories Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Phibro Animal Health Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Non Therapeutic Antibiotics for Food Animals Market, By Application
    • 6.1.1 Livestock
    • 6.1.2 Poultry
    • 6.1.3 Aquaculture
  • 6.2 Non Therapeutic Antibiotics for Food Animals Market, By Product Type
    • 6.2.1 Tetracyclines
    • 6.2.2 Penicillins
    • 6.2.3 Sulfonamides
    • 6.2.4 Macrolides
    • 6.2.5 Aminoglycosides
  • 6.3 Non Therapeutic Antibiotics for Food Animals Market, By Ingredient Type
    • 6.3.1 Chlortetracycline
    • 6.3.2 Oxytetracycline
    • 6.3.3 Sulfamethazine
    • 6.3.4 Tylosin
    • 6.3.5 Neomycin
  • 6.4 Non Therapeutic Antibiotics for Food Animals Market, By Distribution Channel
    • 6.4.1 Veterinary Clinics
    • 6.4.2 Feed Mills
    • 6.4.3 Online Retailers
    • 6.4.4 Farm Supply Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Non Therapeutic Antibiotics for Food Animals Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Non Therapeutic Antibiotics for Food Animals market is categorized based on

By Product Type

• Tetracyclines
• Penicillins
• Sulfonamides
• Macrolides
• Aminoglycosides

By Application

• Livestock
• Poultry
• Aquaculture

By Distribution Channel

• Veterinary Clinics
• Feed Mills
• Online Retailers
• Farm Supply Stores
• Others

By Ingredient Type

• Chlortetracycline
• Oxytetracycline
• Sulfamethazine
• Tylosin
• Neomycin

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim
• Elanco Animal Health
• Ceva Santé Animale
• Phibro Animal Health Corporation
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• Virbac
• PetIQ, Inc.
• Heska Corporation
• Norbrook Laboratories Ltd.
• Tyson Foods, Inc.
• Alltech
• Land O'Lakes, Inc.